Consun Pharmaceutical Group Ltd. filed a next day disclosure return to the Hong Kong Stock Exchange, reporting the repurchase of 1,227,000 ordinary shares at an aggregate price of HKD 241,780. The repurchase was carried out as per the mandate authorized on 22 May 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Consun Pharmaceutical Group Ltd. published the original content used to generate this news brief on June 19, 2025, and is solely responsible for the information contained therein.